MarketPeel
Insider Trading Intelligence
SP

Sean A. Power

TGTX
CHIEF FINANCIAL OFFICER · TG THERAPEUTICS, INC. · CIK 0001538845
FILING MIX · LIFETIME63%/37%
BUYS
10
SELLS
6
TOTAL VALUE
$5.03M
COMPANIES
1
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
798,111
AVG SELL PX
$22.07
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Sean A. Power, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%-3.10%-0.54%-2.56%-0.40%
14d6+83.33%-8.71%-0.32%-8.39%-8.35%
30d6+66.67%-13.78%+0.22%-14.01%-13.28%
60d6+50.00%-17.26%-1.57%-15.69%-21.82%
90d6+66.67%-15.93%-2.48%-13.45%-31.21%
180d6+50.00%-23.30%-0.48%-22.82%-30.95%
1y6+66.67%-6.32%+7.94%-14.25%-21.11%
2y6(2 pending)+25.00%+28.59%+23.59%+5.00%+1.30%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TGTX · 798,111 shares · as of Jan 8, 2026
0199,528399,056598,583798,111202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 10 buys / 6 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,000798,111Jan 8, 2026Jan 9, 2026View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
87,500708,111Jan 29, 2025Jan 30, 2025View →
TGTX
TG THERAPEUTICS, INC.
SALE
CFO
10,021$28.53$285.9K660,611Jan 6, 2025Jan 7, 2025View →
TGTX
TG THERAPEUTICS, INC.
SALE
CFO
11,337$30.29$343.4K670,632Jan 3, 2025Jan 7, 2025View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,000681,969Jan 5, 2024Jan 5, 2024View →
TGTX
TG THERAPEUTICS, INC.
SALE
CFO
47,867$16.91$809.4K606,969Jan 3, 2024Jan 5, 2024View →
TGTX
TG THERAPEUTICS, INC.
SALE
Chief Financial Officer
73,647$26.70$1.97M654,836Jun 2, 2023Jun 5, 2023View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,000728,483Mar 12, 2023Mar 14, 2023View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,000643,483Jul 20, 2022Jul 22, 2022View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000200,000Jul 20, 2022Jul 22, 2022View →
TGTX
TG THERAPEUTICS, INC.
SALE
CFO, Secretary and Treasurer
9,653$18.31$176.7K568,483Jan 5, 2022Jan 5, 2022View →
TGTX
TG THERAPEUTICS, INC.
SALE
CFO, Secretary and Treasurer
75,312$19.20$1.45M578,136Jan 4, 2022Jan 5, 2022View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000653,448Jun 18, 2021Jun 22, 2021View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,000653,338Dec 30, 2020Jan 4, 2021View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000633,338Jul 16, 2020Jul 20, 2020View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,000433,338Jul 16, 2020Jul 20, 2020View →
Other insiders · TGTX
Loading peer insiders…
About this filer
CIK 0001538845
ROLE
Chief Financial Officer
PRIMARY
TGTX
COMPANIES
1
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001538845DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback